Endocrinology, Diabetes & Metabolism Case Reports (Mar 2021)

Pituitary metastasis unveiling a lung adenocarcinoma

  • Ana M Lopes,
  • Josué Pereira,
  • Isabel Ribeiro,
  • Ana Martins da Silva,
  • Henrique Queiroga,
  • Cláudia Amaral

DOI
https://doi.org/10.1530/EDM-20-0211
Journal volume & issue
Vol. 1, no. 1
pp. 1 – 5

Abstract

Read online

Pituitary metastasis (PM) can be the initial presentation of an otherwise unknown malignancy. As PM has no clinical or radiological pathognomonic features, diagnosis is challenging. The authors describe the case of a symptomatic PM that revealed a primary lung adenocarcinoma. A 62-year-old woman with multiple sclerosis and no history of malignancy, incidentally presented with a diffusely enlarged and homogeneously enhancing pituitary gland associated with stalk enlargement. Clinical and biochemical evaluation revealed anterior hypopituitarism and diabetes insipidus. Hypophysitis was considered the most likely diagnosis. However, rapid visual deterioration and pituitary growth raised the suspicion of metastatic involvement. A search for systemic malignancy was performed, and CT revealed a lung mass, which proved to be a lung adenocarcinoma. Accordingly, the patient was started on immunotherapy. Resection of the pituitary lesion was performed, and histopathology analysis revealed metastatic lung adenocarcinoma. Following surgery, the patient underwent radiotherapy. More than 2 years after PM detection, the patient shows a clinically relevant response to antineoplastic therapy and no evidence of PM recurrence.